Navigation Links
China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011
Date:2/9/2011

ares used in computation of earnings per shareBasic22,370,00021,978,242Diluted22,370,00024,061,575Use of Non-GAAP Financial MeasuresGAAP results for the third quarters and nine months ended December 31, 2010 and December 31, 2009, include non-cash losses or gains related to change in fair value of the Company's convertible notes and cash reversion as a result of redemption of the convertible notes. To supplement the Company's condensed consolidated financial statements presented on a GAAP basis, the Company has provided non-GAAP financial information excluding the impact of these items in this release, which are non-GAAP net income and non-GAAP diluted earnings per share. The Company's management believes that these non-GAAP measures provide investors with a better understanding of how the results relate to the Company's historical performance. A reconciliation of adjustments to GAAP results appears in the tables accompanying this press release. This additional non-GAAP information is not meant to be considered in isolation or as a substitute for GAAP financials.

 

Three Months Ended December 31, 2010

2009 Adjusted Net income

Net Income

Diluted EPS

Net Income

Diluted EPSAdjusted Amount

10,416,229

0.44

7,811,082

0.32AdjustmentsNon-cash gains (losses) from change in fair value of convertible bonds

2,847,000

-

2,668,000

0.16Amount per consolidated statement of operations

13,263,229

0.59

10,479,082

0.48
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
2. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
3. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
4. China-Biotics, Inc. Announces US$20 million Share Buyback Program
5. China-Biotics, Inc. Comments on Market Rumors
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Spherix Reports Second Quarter Earnings
8. Tapestry Reports Second Quarter 2007 Results
9. Callisto Reports on Second-Quarter 2007 Milestones
10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... and Markets ( http://www.researchandmarkets.com/research/63gppw/asian_dermatology ) has announced the ... by End User - Forecast to 2019" report to ... estimated to grow at a CAGR of 11.3% from 2014 ... share in the Dermatology devices market around 28.8% in 2014 ... Devices market holds a high potential for growth in future ...
(Date:5/1/2015)... At the American Association of Neurological Surgeons (AANS) Annual ... , Elekta will highlight Leksell Gamma Knife® Registry ... enormous amount of data – generated by thousands of ... advance clinical research and further optimize patient care. ... allows practitioners to store, retrieve, and analyze Gamma Knife ...
(Date:5/1/2015)... Calif., May 1, 2015 Pharmacyclics, Inc. (the ... for the quarter ended March 31, 2015, as well ... AbbVie Inc., no conference call will be held. ... quarter ended March 31, 2015 increased to $206 million ... 2014. , Worldwide IMBRUVICA ® (ibrutinib) net ...
Breaking Medicine Technology:Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 2Elekta to showcase Leksell Gamma Knife Registry at AANS Annual Meeting 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32
... WOODCLIFF LAKE, N.J., Oct. 14 Par Pharmaceutical Companies, Inc. ... a "Modified Dutch Auction" tender offer for a portion of ... 2010. , Under the "Modified Dutch Auction" procedure, Par is ... aggregate principal amount, or up to approximately 82.7%, of the ...
... In the United States, a woman is diagnosed with breast ... Except for skin cancers, breast cancer is the most ... To help fight this disease, eMed-ID, the world,s first emergency ... Personal Health Records (PHR) wristband sold to raise awareness during ...
Cached Medicine Technology:Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010 2Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010 3Par Pharmaceutical Announces 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Notes due 2010 4Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available 2Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available 3
(Date:5/2/2015)... As one of only 30 Illinois companies to ... Achievement and Recognition Program (SHARP) certification, Essentra Specialty ... Illinois Department of Labor to host this special event. ... by the Occupational Safety and Health Administration’s (“OSHA”) Onsite ... meet or exceed all of the necessary regulations and ...
(Date:5/2/2015)... York, NY (PRWEB) May 02, 2015 ... when a deadly natural disaster strikes anywhere on this ... to leverage human sympathy and compassion for their own ... (United States Computer Emergency Readiness Team) issued an ... users “of potential email scams citing the earthquake in ...
(Date:5/2/2015)... As a nonsurgical staple in the ... neck and décolleté, radiofrequency energy is proving to ... the success of vulvovaginal rejuvenation. In a pilot ... ThermiGyn’s Women’s Health Clinical Advisory Board Chairman Red ... temperature controlled radio frequency, specifically that of ThermiVa, ...
(Date:5/1/2015)... 2015 Pioneer Millworks, the largest reclaimed ... in their reclaimed wood products at the 27th annual ... Center in NYC this May. Their newest offerings, Vat ... anticipated texture and color to North America's platform for ... texture and color in the design world and we're ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 It’s raining bills ... House introducing proposals to expand federal support for telemedicine. ... that ATA has been working with Congress,” said Jonathan Linkous, ... signify how the nation is poised to embrace the use ... one more step in fulfilling ATA’s mission to improve quality, ...
Breaking Medicine News(10 mins):Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2
... Services Panel That,Nursing Home Staffing and Quality Programs Are ... testimony,before a field hearing of the House Human Services ... (THCA) said that in order to,protect the Houston area,s ... essential in the year ahead to initiate a much-needed,discussion ...
... (IOF) has welcomed the recently published paper European ... in postmenopausal women(1) from the European Society for ... (ESCEO). , This paper constitutes a roadmap for ... tool based on the WHO technical report, Assessment ...
... access to top U.S. hospitals and doctors competing on the ... basis of quality, ... America (HPAM) offers,a specialty network for high value medical procedures ... rated medical centers,of excellence throughout the United States. These providers ...
... Online Ads, Bilingual Radio,Jingles, Resources for Parents, Older ... The Health Resources,and Services Administration (HRSA) has ... National Poison Prevention Week, March 16-22., The ... in the United States. This past year, more ...
... The American Academy of Cosmetic Surgery 2007 Procedural Survey ... 2226.3% increase in male sclerotherapy since ... of Cosmetic,Surgery (AACS) is pleased to announce the results ... polling the Academy,s U.S.-based,members., Findings conclude that sclerotherapy, ...
... the only curative treatment in patients with bile ... reliable diagnostic procedure is of great importance in ... the bile duct, imaging techniques including ultrasound, computed ... sensitivity for the detection of bile duct cancer. ...
Cached Medicine News:Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 2Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 3Health News:Increased Investment in Medicaid Needed to Protect Houston Area's Most Vulnerable Seniors, Disabled 4Health News:IOF recognizes ESCEO European guidance for osteoporosis diagnosis and management 2Health News:The Healthplace America(TM) Benefit Delivers a Better Option in Healthcare 2Health News:HRSA Launches Digital Campaign to Promote Poison Awareness and Prevention 2Health News:Men are Opting to Remove Spider Veins Over Replacing Hair 2
... Harmony Special Peristaltic phacoemulsification system features microprocessor ... individual programmability and remote control for all ... front panel with color coded function modes ... ease of use and viewing. Under control ...
The D.O.R.C. Silicone Oil is an ultra purified silicone oil which leads a maximum interfacial tension and minimizes interactions between tissues, cells and endo-tamponades media. (Sterile, 10 ml.)...
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r...
Silver Foley Catheter 2-way...
Medicine Products: